Compare Supplements

No approved or recommended dose — bimagrumab is an investigational monoclonal antibody, not an approved medicine or a supplement. We do NOT provide a dosing protocol. In trials it was given by INTRAVENOUS infusion every 4 weeks (10 mg/kg, up to ~1200 mg, in the type-2-diabetes/obesity study; 1, 3, or 10 mg/kg in the inclusion-body-myositis trials). Some early studies dosed subcutaneously, but the pivotal trials used IV infusion. These were monitored clinical-trial regimens, not a recommendation for any self-use.

Any time

None — investigational antibody with no approved or commercial form

• Not an approved medicine and not a dietary supplement — investigational biologic; do not self-source
• No established self-administration safety data; given only by infusion in monitored trials
• Pregnancy and breastfeeding (unstudied; bimagrumab transiently alters reproductive-hormone/FSH-axis signalling)

• Fertility / reproductive-hormone treatments
• GLP-1 receptor agonists / other weight-loss drugs
• Any prescription medication